CV-4-26

N/A

Report date: 2024/09/20 14:48:08
NME

Base Information

Drug NameCV-4-26
Drug Alias NameCV-4-26
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of FloridaTulane University
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of FloridaTulane University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A